You are not logged in.

Request for Proposals (RFP) - Supply of non-injectable testosterone products


Tender Closed
RFx ID : 25694911
Tender Name : Request for Proposals (RFP) - Supply of non-injectable testosterone products
Reference # : A1581341
Open Date : Thursday, 24 November 2022 10:00 AM (Pacific/Auckland UTC+13:00)
Close Date  : Thursday, 19 January 2023 4:00 PM (Pacific/Auckland UTC+13:00)
Tender Type : Request for Proposals (RFP)
Tender Coverage : Sole Agency  [?]
Categories :
  • 51000000 - Drugs and Pharmaceutical Products
  • New Zealand
Exemption Reason : None
Required Pre-qualifications : None
Contact : Procurement Team
Alternate Physical Delivery Address  :
Alternate Physical Fax Number  :
Agency Address :

REQUEST FOR PROPOSALS – Supply of non-injectable testosterone products.

This request for proposals (RFP) letter incorporates the following schedules:
• Schedule 1 specifies the pharmaceuticals for which Pharmac is requesting proposals and sets out the background to the RFP and the types of proposals sought.
• Schedule 2 describes the process that Pharmac expects to follow in relation to the RFP.
• Schedule 3 sets out information about the estimated size of the current subsidised market for the pharmaceuticals.
• Schedule 4 contains the RFP form in which you are to provide details of your proposal.

The other attachments in addition to the RFP letter on this GETS listing are an editable version of the proposal form and Pharmac's standard terms and conditions for supply of pharmaceuticals that would form the basis of the contract for supply.

If you wish to submit a proposal, you must submit it to Pharmac via the Government Electronic Tenders Service (GETS) ( no later than 4.00 p.m. on Thursday 19 January 2023.

If you have any questions about this RFP, please post these on GETS before 23/12/22 or alternatively contact Pharmac by email at Responses to all questions will be published on GETS.

RFx Outcome

This tender has been awarded.

  • PHARMACO (N.Z.) LIMITED - 4, Fisher Crescent, Mount Wellington, Auckland, 1060, NEW ZEALAND

Further Award Information:
Te Pātaka Whaioranga (Pharmac)
Level 9, 40 Mercer Street Wellington
PO Box 10254, Wellington 6143, New Zealand

Pharmac is pleased to announce the approval of a market share agreement progressed through an open RFP for supply of non-injectable testosterone products.

Pharmac has decided to award Principal Supply Status (“PSS”) to Pharmaco for the supply of testosterone gel to community pharmacies and Te Whatu Ora hospitals, with a 5% Alternative Brand Allowance (“ABA”). There are no changes proposed to the other forms of testosterone currently listed on the Pharmaceutical Schedule as a result of this RFP.

In summary this will result in:

• Pharmaco’s brand of testosterone gel (Testogel), being listed in the Pharmaceutical Schedule from 1 April 2024.
• Testogel having PSS from 1 July 2024 until 30 June 2027.

Please note:

• This agreement eventuating from this process was provisional on consultation and final approval from the Pharmac Board or its delegate. The notification date is the ‘approval’ or award date.
• The 8 February 2024 award notification is available on the Pharmac website here:
• More information about PSS is available here:
• The approximate forecasted gross annual expenditure across all testosterone presentations is $2 – 3 million.
• Pharmac is committed to sustainable and inclusive procurement that delivers for New Zealand and New Zealanders. Broader outcomes were considered in this process.

Award Date: Thursday, 8 February 2024 (Pacific/Auckland UTC+13:00)
Date RFx was completed/updated: Thursday, 21 March 2024 3:11 PM (Pacific/Auckland UTC+13:00)